ADVERTISEMENT
ICICI Securities: Natco Pharma To Launch First Generic Revlimid
Natco Pharma would become the first company to launch Revlimid in March 2022 due to Dr. Reddy’s settlement with Celgene.
18 Sep 2020, 02:48 PM IST 
An employee holds tablets on the production line at pharmaceutical plant (Photographer Oliver Bunic/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
